Improving Patient Outcomes for Unhealthy Alcohol Use and AUD
Improving Patient Outcomes Through Screening, Follow-Up and Treatment for Unhealthy Alcohol Use and Alcohol Use Disorder
Estimate Time for Completion: 90 minutes
Unhealthy alcohol use is a common and serious issue, ranging from risky drinking to alcohol dependence and alcohol use disorder (AUD). Unhealthy alcohol use occurs on a spectrum. About 26% of adults in the United States report that they engage in “risky or hazardous drinking”—drinking more than the recommended limits for daily, per-occasion or weekly amounts—resulting in increased risk for health consequences.
This course will provide health care professionals with the education needed to facilitate proper screening, follow-up and treatment for unhealthy alcohol use and AUD. It will also educate participants on the capability of telehealth as a modality to effectively engage patients to improve outcomes and reduce disease burden.
This program is supported by an independent educational grant from Alkermes.
This education program is geared toward members of interdisciplinary health care teams (physicians, nurses, physician assistants, pharmacists, psychologists, social workers and others) practicing in primary care settings.
After successful completion of this activity, learners will be able to:
- Discuss strategies and tools to screen for unhealthy alcohol use and AUD.
- Distinguish between recommended treatment options based on severity of unhealthy alcohol use and AUD.
- Reduce barriers to treatment initiation for patients with AUD.
- Recognize the appropriateness of pharmacotherapy as part of the outpatient treatment plan for patients with moderate to severe AUD.
- Explore factors that influence and improve retention in treatment for patients with AUD.
- Utilize telemedicine effectively as a tool for screening, follow-up and treatment of unhealthy alcohol use and AUD.
Module 1: Disease Burden
Module 2: Patient Stories
Module 3: Screening and Follow-Up
Module 4: Treatment Options
Module 5A: Telehealth Overview
Special thanks to the American Telemedicine Association for their assistance with this module.
Module 5B: Telemedicine and AUD
Henry Kranzler, M.D.
Henry R. Kranzler, M.D. is Professor of Psychiatry and Director of the Center for Studies of Addiction at the University of Pennsylvania’s Perelman School of Medicine. His research focuses on the genetics and pharmacological treatment of substance dependence, with a particular emphasis on precision addiction medicine. His research has been continuously supported since 1987 by grants from the National Institutes of Health. He has authored or co-authored more than 500 journal articles, book chapters, and books, is a member of the editorial board of five peer-review journals, and is the Editor of Alcoholism: Clinical and Experimental Research. His work currently focuses on the molecular genetics of substance dependence and the personalized treatment of alcohol, opioid, and nicotine use disorders using a pharmacogenetic approach.
Dr. Kranzler has the following disclosures:
Dr. Kranzler is a scientific advisory board member for Dicerna Pharmaceuticals, Sophrosyne Pharmaceuticals, and Enthion Pharmaceuticals; a consultant for Sobrera Pharmaceuticals; the recipient of research funding and medication supplies for an investigator-initiated study from Alkermes; named as an inventor on PCT patent application #15/878,640 entitled: "Genotype-guided dosing of opioid agonists," filed January 24, 2018; and a member of the American Society of Clinical Psychopharmacology's Alcohol Clinical Trials Initiative (ACTIVE Group), which over the past three years was supported by Alkermes, Dicerna, Ethypharm, Lundbeck, Mitsubishi, and Otsuka.
Lewei Allison Lin, M.D.
Allison Lin, MD is an addiction psychiatrist and Assistant Professor in the Department of Psychiatry as well as a research investigator at the VA Center for Clinical Management Research. She investigates ways to improve treatment for patients with opioid and other substance use disorders and uses large electronic health datasets to better understand medical, mental health and other correlates for patients with substance use disorders. Dr. Lin is interested in developing telehealth interventions to improve access to evidence based treatments for substance use disorders and to better understand disparities in treatment.
Dr. Lin has no financial relationships to disclose relating to the subject matter of this presentation.
Joseph Brennan is an advisor to the American Telemedicine Association and a telehealth consultant at Moonshot Health Consulting. Prior to starting Moonshot Health Consulting, he served as Senior Director of the Virtual Health program at Spectrum Health based in Western Michigan. He has worked with many healthcare organizations on the development and scale of telehealth including the recent launch of Yale New Haven Health's Video Care OnDemand program and rapid expansion in response to COVID-19. Joe has championed several pioneering components of a telehealth program, including a robust dashboard for outcomes analytics, a custom developed mobile app, and a digitally-driven, multimodal advertising strategy. He has been an advocate for telehealth at both the state and federal levels of government, testifying before the Michigan House of Representatives and the Michigan Senate about the positive impact of telehealth . Joe is bronze certified in Lean Process Improvement and LEAD certified in the Stanford Design Thinking Process. Prior to his work in telehealth, Joe served in various positions in technology and start-up entrepreneurship.
Mr. Brennan has no financial relationships to disclose relating to the subject matter of this presentation.
All of the relevant financial relationships listed for these individuals have been mitigated.
In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide Interprofessional Continuing Education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
This educational activity is approved for: 1.5 AMA PRA Category 1 CreditTM and ACPE.
This educational activity is approved for 1.5 nursing contact hours.*
The assigned universal program number: JA0004597-0000-21-002-H04-P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.
This program grants 2.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts. This program is not considered a required CCE quarterly webinar.
* Please note – You must attend the entire program to be eligible for total number of contact hours.
ATTENTION: Effective February 1, 2022, this on-demand (enduring material) activity no longer offers credits for the American Academy of Physician Assistants (AAPA), the American Psychological Association (APA), or the Association of Social Work Boards (ASWB). Only applicable professionals who fully completed this on-demand activity prior to February 1, 2022, are eligible for AAPA, APA, or ASWB credits. No other CEUs are impacted by this change.
- 1.50 ACPE
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 IPCE
- 1.00 Participation
- 2.00 PCMH CCE